Complete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantation.

ABSTRACT:

Background and aims

Hepatocyte transplantation for genetic liver diseases has several potential advantages over gene therapy. However, the low efficiency of cell engraftment has limited its clinical implementation. This problem could be overcome by selectively expanding transplanted donor cells until they replace enough of the liver mass to achieve therapeutic benefit. We previously described a gene therapy method to selectively expand hepatocytes deficient in cytochrome p450 reductase (Cypor) using acetaminophen (APAP). Because Cypor is required for the transformation of APAP to a hepatotoxic metabolite, Cypor-deficient cells are protected from toxicity and are able to expand following APAP-induced liver injury. Here, we apply this selection system to correct a mouse model of phen

SUBMITTER: Vonada A 

PROVIDER: S-EPMC11559556 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature